UK markets open in 35 minutes

Cyteir Therapeutics, Inc. (CYT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.6200-0.2400 (-8.39%)
At close: 04:00PM EDT
2.6200 0.00 (0.00%)
After hours: 05:01PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
Operating expenses
Research development
35,434
30,959
16,765
12,768
Selling general and administrative
13,619
11,300
4,178
3,345
Total operating expenses
49,053
42,259
20,943
16,105
Operating income or loss
-49,053
-42,259
-20,943
-16,105
Total other income/expenses net
137
133
120
1,061
Income before tax
-48,916
-42,126
-20,823
-15,044
Income from continuing operations
-48,916
-42,126
-20,823
-15,044
Net income
-48,916
-42,126
-20,823
-15,044
Net income available to common shareholders
-48,916
-42,126
-20,823
-15,044
Basic EPS
-
-2.16
-1.07
-0.77
Diluted EPS
-
-2.16
-1.07
-0.77
Basic average shares
-
19,499
19,434
19,434
Diluted average shares
-
19,499
19,434
19,434
EBITDA
-
-41,780
-20,592
-15,890